GLARICON Injection Insulin Glargine100 IU/ml 5×3

Subcutaneous
Type 1 or 2 Diabetes Mellitus
Initial dose
Type 1 diabetes mellitus: Starting dose should be approximately one third of the total daily insulin requirements; short-acting, premeal insulin should be used to satisfy the remaining two thirds of the daily insulin requirements; insulin glargine should be used in combination with a short-acting or rapid-acting insulin;

Type 2 diabetes mellitus: Starting dose in patients who are not currently treated with insulin is 10 units (or 0.2 unit/kg) once daily
Dosage should be individualized in accordance with the needs of the patient and adjusted according to blood glucose measurement